What is Immunome's EV / sales?

Immunome (IMNM) reported EV / sales of 472× in Q1 2026.

How has Immunome's EV / sales changed year-over-year?

Immunome's EV / sales increased by 1453.6% year-over-year, from 30.4× to 472×.

What is the long-term trend for Immunome's EV / sales?

Over 2 years (2023 to 2025), Immunome's EV / sales has grown at a 210.6% compound annual growth rate (CAGR), from 25.7× to 247.9×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Immunome IMNM EV / sales

EV / sales at other companies

PfizerPFE

3.5×+0.3×

Arcus BiosciencesRCUS

11.1×+6.1×

Nuvation BioNUVB

9.9×-41.1×

IDEAYA Biosciences, Inc.IDYA

308×+215×

ImmunityBio, Inc.IBRX

57.9×-33.2×

Summit TherapeuticsSMMT

8,448.1×+8,132×

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Calculated from Immunome’s reported figures.

enterprise value/total revenue=472×

Based on the most recent quarter.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's EV / sales?: Immunome (IMNM) reported EV / sales of 472× in Q1 2026.
How has Immunome's EV / sales changed year-over-year?: Immunome's EV / sales increased by 1453.6% year-over-year, from 30.4× to 472×.
What is the long-term trend for Immunome's EV / sales?: Over 2 years (2023 to 2025), Immunome's EV / sales has grown at a 210.6% compound annual growth rate (CAGR), from 25.7× to 247.9×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.